DK0883628T3 - 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling - Google Patents

17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling

Info

Publication number
DK0883628T3
DK0883628T3 DK96942491T DK96942491T DK0883628T3 DK 0883628 T3 DK0883628 T3 DK 0883628T3 DK 96942491 T DK96942491 T DK 96942491T DK 96942491 T DK96942491 T DK 96942491T DK 0883628 T3 DK0883628 T3 DK 0883628T3
Authority
DK
Denmark
Prior art keywords
17beta
derivatives
thiode
thioandrosteine
oxo
Prior art date
Application number
DK96942491T
Other languages
English (en)
Inventor
Keith Biggadike
Panayiotis Alexandro Procopiou
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526677.1A external-priority patent/GB9526677D0/en
Priority claimed from GBGB9613120.6A external-priority patent/GB9613120D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0883628T3 publication Critical patent/DK0883628T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96942491T 1995-12-29 1996-12-19 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling DK0883628T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9526677.1A GB9526677D0 (en) 1995-12-29 1995-12-29 Compounds
GBGB9613120.6A GB9613120D0 (en) 1996-06-21 1996-06-21 Compounds
PCT/GB1996/003138 WO1997024368A1 (en) 1995-12-29 1996-12-19 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof

Publications (1)

Publication Number Publication Date
DK0883628T3 true DK0883628T3 (da) 2000-11-06

Family

ID=26308405

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942491T DK0883628T3 (da) 1995-12-29 1996-12-19 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling

Country Status (11)

Country Link
US (1) US6114318A (da)
EP (1) EP0883628B1 (da)
JP (1) JP2951000B2 (da)
AT (1) ATE195529T1 (da)
AU (1) AU1185197A (da)
DE (1) DE69609870T2 (da)
DK (1) DK0883628T3 (da)
ES (1) ES2150149T3 (da)
GR (1) GR3034439T3 (da)
PT (1) PT883628E (da)
WO (1) WO1997024368A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE260931T1 (de) * 1997-06-30 2004-03-15 Glaxo Group Ltd Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
JP3847065B2 (ja) * 2000-08-21 2006-11-15 松下電器産業株式会社 地点登録装置
ITRM20020458A1 (it) * 2002-09-13 2004-03-14 Ambiotec S A S Di Ammendola Sergio Procedimento per la separazione preparativa degli epimeri di steroidi.
JP2012530140A (ja) 2009-06-16 2012-11-29 メルク・シャープ・アンド・ドーム・コーポレーション グルココルチコイド受容体アゴニストとしての新規[3,2−c]ヘテロアリールステロイド、組成物およびこの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481144A (en) * 1984-02-03 1984-11-06 E. R. Squibb & Sons, Inc. 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
ES2107806T3 (es) * 1992-12-24 1997-12-01 Rhone Poulenc Rorer Ltd Nuevos esteroides.

Also Published As

Publication number Publication date
EP0883628A1 (en) 1998-12-16
ATE195529T1 (de) 2000-09-15
EP0883628B1 (en) 2000-08-16
ES2150149T3 (es) 2000-11-16
WO1997024368A1 (en) 1997-07-10
DE69609870T2 (de) 2001-01-25
PT883628E (pt) 2001-01-31
JPH11501674A (ja) 1999-02-09
US6114318A (en) 2000-09-05
DE69609870D1 (de) 2000-09-21
GR3034439T3 (en) 2000-12-29
AU1185197A (en) 1997-07-28
JP2951000B2 (ja) 1999-09-20

Similar Documents

Publication Publication Date Title
ATE193883T1 (de) Verbindungen und ihre zusammensetzungen mit entzündungshemmenden und anti-thrombotischen wirkungen
NO962286D0 (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
AP9801274A0 (en) Lactone derivatives of 17, beta.carboxy, carbothio and amide androstane derivatives.
DE69308029D1 (de) 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOCHINOLINAMINE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS THERAPEUTIKA
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
DE69523622D1 (de) Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE59410304D1 (de) N-substituierte azabicycloheptan-derivate und ihre verwendung, z.b., als neuroleptika
DK0883628T3 (da) 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
TR199800296T1 (xx) Esterler.
DK0876393T3 (da) 21-(2-oxo-tetrahydrofuran)-thio-pregnanderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indehold
DE59307133D1 (de) Gestagen wirksame 19,11-überbrückte 4-estrene
IL117083A (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical compositions containing these compounds
ATE150026T1 (de) Benzo(f>chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln
NO952926L (no) Fremgangsmåte for fremstilling av C-substituerte dietylentriaminer
DE69916103D1 (de) 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie
ES2107281T3 (es) Nuevos derivados de acetaldehido, su procedimiento de preparacion y su aplicacion.